ResMed Performance

RMD -- USA Stock  

USD 108.81  0.39  0.36%

ResMed has performance score of 0 on a scale of 0 to 100. The organization holds Beta of 0.0 which implies the returns on MARKET and ResMed are completely uncorrelated. Although it is extremely important to respect ResMed current trending patterns, it is better to be realistic regarding the information on equity existing price patterns. The philosophy towards forecasting future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing ResMed technical indicators you can presently evaluate if the expected return of 0.0% will be sustainable into the future. ResMed right now holds a risk of 0.0%. Please check ResMed Information Ratio, Value At Risk as well as the relationship between Value At Risk and Expected Short fall to decide if ResMed will be following its historical price patterns.
 Time Horizon     30 Days    Login   to change

ResMed Relative Risk vs. Return Landscape

If you would invest  10,881  in ResMed on June 20, 2018 and sell it today you would earn a total of  0.00  from holding ResMed or generate 0.0% return on investment over 30 days. ResMed is generating negative expected returns assuming volatility of 0.0% on return distribution over 30 days investment horizon. In other words, 0% of equities are less volatile than the company and above 99% of equities are expected to generate higher returns over the next 30 days.
 Daily Expected Return (%) 
      Risk (%) 

ResMed Market Risk Analysis

Sharpe Ratio = 0.0
Good Returns
Average Returns
Small Returns
Based on monthly moving average ResMed is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ResMed by adding it to a well-diversified portfolio.

Performance Rating

ResMed Risk Adjusted Performance Analysis

Risk-Adjusted Performance

Over the last 30 days ResMed has generated negative risk-adjusted returns adding no value to investors with long positions.

ResMed Alerts

Equity Alerts and Improvement Suggestions
About 64.0% of the company shares are owned by institutional investors
Additionally take a look at Your Equity Center. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.